home / stock / ovid / ovid quote
Last: | $0.74 |
---|---|
Change Percent: | -1.56% |
Open: | $0.7506 |
Close: | $0.7517 |
High: | $0.7671 |
Low: | $0.74 |
Volume: | 68,262 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.74 | $0.7506 | $0.7517 | $0.7671 | $0.74 | 68,262 | 07-05-2024 |
$0.7517 | $0.7904 | $0.7517 | $0.7949 | $0.7322 | 336,114 | 07-04-2024 |
$0.7517 | $0.7904 | $0.7517 | $0.7949 | $0.7322 | 336,114 | 07-03-2024 |
$0.7734 | $0.8726 | $0.7734 | $0.8826 | $0.773 | 834,042 | 07-02-2024 |
$0.8622 | $0.73 | $0.8622 | $0.9 | $0.73 | 2,330,323 | 07-01-2024 |
$0.7692 | $0.721 | $0.7692 | $0.7841 | $0.720258 | 3,272,806 | 06-28-2024 |
$0.7264 | $0.71 | $0.7264 | $0.7275 | $0.6892 | 829,755 | 06-27-2024 |
$0.7126 | $0.7 | $0.7126 | $0.72 | $0.68 | 2,663,694 | 06-26-2024 |
$0.7 | $0.7929 | $0.7 | $0.7929 | $0.69435 | 3,210,150 | 06-25-2024 |
$0.79 | $0.78 | $0.79 | $0.8412 | $0.751001 | 1,941,690 | 06-24-2024 |
$0.78 | $0.711 | $0.78 | $0.78 | $0.6903 | 1,641,820 | 06-21-2024 |
$0.701 | $0.761 | $0.701 | $0.7793 | $0.6925 | 2,331,288 | 06-20-2024 |
$0.7879 | $0.7596 | $0.7879 | $0.8684 | $0.7452 | 4,238,494 | 06-19-2024 |
$0.7879 | $0.7596 | $0.7879 | $0.8684 | $0.7452 | 4,238,494 | 06-18-2024 |
$0.7896 | $1.1 | $0.7896 | $1.17 | $0.75175 | 22,285,201 | 06-17-2024 |
$3.29 | $3.16 | $3.29 | $3.31 | $3.12 | 129,291 | 06-14-2024 |
$3.2 | $3.2 | $3.2 | $3.21 | $3.1 | 262,453 | 06-13-2024 |
$3.2 | $3.19 | $3.2 | $3.305 | $3.15 | 112,894 | 06-12-2024 |
$3.11 | $3.1 | $3.11 | $3.128 | $3 | 76,897 | 06-11-2024 |
$3.1 | $2.95 | $3.1 | $3.115 | $2.89 | 134,554 | 06-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
Ovid Therapeutics Inc. Company Name:
OVID Stock Symbol:
NASDAQ Market:
Ovid Therapeutics Inc. Website:
The Phase 1 study for OV888/GV101 capsule met its objective, demonstrating a favorable safety and tolerability profile with no serious adverse events Secondary endpoint results indicate that the target pharmacokinetic profile was achieved at the targeted clinical dose, supporting once daily d...
2024-06-18 10:30:03 ET B. Riley analyst issues BUY recommendation for OVID on June 18, 2024 09:12AM ET. The previous analyst recommendation was Buy. OVID was trading at $0.7744 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analy...
2024-06-18 07:15:06 ET BTIG analyst issues BUY recommendation for OVID on June 18, 2024 04:51AM ET. The previous analyst recommendation was Buy. OVID was trading at $0.7896 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst r...